Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Estimating the Impact of Sexuality Education and Mobile Health Services on Reproductive Health and Empowerment Among Adolescents in Sierra Leone for the Family Planning Impact Lab (REACH)

30 september 2026 bijgewerkt door: Guttmacher Institute

REACH Study: Reproductive Empowerment for Adolescents Through CAHLS and Health Services (FPIL Sierra Leone Component)

The goal of this randomized controlled trial is to learn if comprehensive sexuality education (CSE) and access to mobile sexual and reproductive health (SRH) services in secondary schools can improve short- and long-term health, well-being, social and economic outcomes among adolescents and young people in two districts of Sierra Leone. The main questions it aims to answer are:

  1. How do CSE and mobile SRH services (individually and combined) change adolescent SRHR, well-being and socioeconomic outcomes in the short term and in the longer term (over 3 years)?
  2. What are the economic costs of providing CSE and mobile SRH services?
  3. How cost-effective is the provision of CSE and mobile SRH services, given its potential impact on health, socioeconomic, and well-being outcomes?
  4. To what extent are CSE and mobile SRH services being implemented according to the original plan and timeline?

Researchers will compare schools receiving CSE and mobile SRH services to schools not receiving these services, to see if adolescent SRHR, well-being and socioeconomic outcomes are better in those schools that received the services. The trial will compare four groups of schools, each with 60 participating schools:

  1. No additional services (control schools)
  2. Only CSE
  3. Only mobile SRH services
  4. CSE and mobile SRH services

The implementation of these services will be led by Marie Stopes Sierra Leone (MSSL) in collaboration with the Ministry of Education. MSSL will ensure that participating schools:

  • Attend teacher training on the CSE curriculum before the study starts, followed by yearly refresher training during the study
  • Have sufficient time allocated to CSE in the weekly school schedule
  • Have adequate teaching materials & equipment to teach CSE
  • Have guidance counsellors in each school who will monitor the implementation of CSE
  • Have a designated "safe space" which adolescents can access for menstrual products and care.
  • Have access to mobile SRH services (provided by MSSL staff) on the school premises 3 times per school year

Studie Overzicht

Gedetailleerde beschrijving

This study aims to evaluate the short- and long-term health, social and economic impacts of a school-based comprehensive sexuality education (CSE) program and improved access to sexual and reproductive health and rights (SRHR) services via mobile outreach to schools, both separately and in combination. This study is part of the Family Planning Impact Lab (FPIL), a five-year research initiative to generate new experimental evidence of the longer-term health, wellbeing, and development outcomes and on the cost-effectiveness of family planning interventions, which includes three randomized controlled trials evaluating family planning interventions in underserved settings in sub-Saharan Africa (RCT1: Sierra Leone; RCT2: Somalia and South Sudan; RCT3: Chad).

Early marriage is common in Sierra Leone, with 13% of young girls marrying before age 15 and 30% before 18, meaning that many girls begin sexual activity and childbearing in adolescence. Married adolescents aged 15-19 have the highest unmet need for family planning (27.8%) of any age group, limiting their ability to delay or space pregnancies. Unmarried adolescents face social barriers to accessing contraception, such as social stigma and male partner disapproval of contraceptive use. Forty percent of young people (15-24) in Sierra Leone did not use a method of contraception at their last sexual intercourse, even though they did not want to become pregnant. Sierra Leone ranks among the top ten countries with the highest teenage pregnancy rates globally, estimated to range between 28.3% and 34%. At the same time, inequitable gender norms leave young women and girls vulnerable to transactional sex, sexual abuse, and other forms of sexual exploitation. Together, these factors reinforce a cycle of limited reproductive autonomy, early and unintended pregnancies, and heightened maternal health risks among adolescent girls.

CSE is an evidence-based approach to improve adolescent SRHR and wellbeing outcomes, including reducing early and unintended pregnancy, HIV, and gender-based violence, as well as building skills for greater autonomy. In Sierra Leone, CSE is being implemented through the Child and Adolescent Health and Life Skills (CAHLS) curriculum, integrated into the national curriculum in 2020. However, rollout has been limited due to resource and training constraints. The effectiveness of CSE also depends on the availability and accessibility of youth-friendly SRHR services, which in Sierra Leone remains weak. A 2018 UNFPA assessment found that only one-third of the facilities had adequate space to provide youth-friendly services. These limitations restrict adolescents' ability to translate knowledge gained from CSE into safer behaviors or timely care-seeking. There is an urgent need for evidence that assesses the impact of linking school-based CSE with accessible, youth-friendly SRH services on SRHR outcomes for adolescents. Despite recent policy commitments and the ongoing rollout of the CAHLS curriculum, no robust studies have examined the impact of such integrated approaches in Sierra Leone. This study aims to fill that gap by generating evidence on the effectiveness of CSE programs that connect learning with health service access, to inform the ongoing national efforts to strengthen adolescent SRHR.

Researchers will use a randomized controlled trial (RCT) design with four arms to evaluate the effectiveness of the two study interventions (CSE and mobile SRHR services) to impact a specific set of reproductive and sexual health, empowerment and well-being outcomes among adolescents in two provinces in Sierra Leone. The four arms, each with 60 schools, will consist of: 1) no intervention (control schools), 2) CSE only, 3) mobile SRHR services only, and 4) CSE and mobile SRHR services. Additionally, researchers will assess the cost-effectiveness of the two primary interventions and the extent to which the interventions are delivered with planned fidelity.

The two study interventions can be envisioned within the context of programs to address both supply and demand within a rights-based framework. As part of the demand-side intervention, the implementing partner Marie Stopes Sierra Leone (MSSL) will train teachers in intervention schools to teach CSE, and will organize necessary equipment, materials and oversight of the CSE program in each school. To address the key supply-side gaps that most affect youth, mobile SRH services will be provided directly on school premises by trained MSSL providers. MSSL has been providing high-quality and affordable SRH services to the most vulnerable and difficult-to-reach populations across all districts of Sierra Leone since 1986, and has also played an integral role in developing the overall CSE strategy and piloting initial CAHLS rollout in schools in collaboration with the Ministry of Basic and Senior Secondary Education.

Studietype

Ingrijpend

Inschrijving (Geschat)

5300

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Contact Back-up

Studie Locaties

      • Freetown, Sierra Leone
        • 240 schools in Kambia and Kenema districts (confidential, cannot be disclosed)
        • Contact:
        • Hoofdonderzoeker:
          • Francis Moses

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

12 jaar tot 17 jaar (Kind)

Accepteert gezonde vrijwilligers

Ja

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Aged 12 to 17 at baseline
  • Enrolled in the lowest grade (JSS1) of one of the junior secondary schools selected for the study in September 2026
  • Provided assent to participate in the research

Exclusion Criteria:

  • Individuals unable to provide assent due to cognitive impairment or severe mental illness
  • Individuals whose guardians opted them out

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Onderzoek naar gezondheidsdiensten
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Faculteitstoewijzing
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Geen tussenkomst: Control schools

The 60 schools in this arm are the control group. They will continue providing their standard services and functions. They will not implement the Comprehensive Sexuality Education curriculum nor will they receive mobile SRH services.

Experimenteel: CSE only

The 60 schools in this arm will implement the Comprehensive Sexuality Education (CSE) curriculum and offer a safe space for menstrual hygiene and care.

For junior secondary schools in the "CSE only" and "CSE+mobile SRH services" intervention arms, at baseline at the start of the school year, MSSL will train teachers who teach subjects in which CSE topics are included, using a standard teaching training curriculum to help mitigate the risk of variability in the quality of CSE implementation across schools. Teachers will then implement the CSE curriculum in their classes throughout the duration of the study. MSSL will provide yearly refresher teacher training throughout the study. In each school, guidance counselors will be tasked with monitoring implementation of the intervention. MSSL will provide all materials and equipment needed to teach CSE. Each school will create a "safe space" where students can go for menstrual hygiene and care.

Andere namen:
  • CSE
  • Child and Adolescent Health and Life Skills (CAHLS) - name used by the Ministry of Education to refer to the CSE curriculum
Experimenteel: Mobile SRH services only

The 60 schools in this arm will receive MSSL-provided mobile sexual and reproductive health (SRH) outreach services on the school premises 3 times per school year.

For junior secondary schools in the "Mobile SRH services only" and "CSE+mobile SRH services" intervention arms, MSSL will utilize three mobile clinical teams to provide direct, comprehensive SRHR services on-site at schools. Each team will be composed of two service providers trained to provide youth-friendly services, one data imputer, and a transport assistant. The team will visit each school once per quarter (3 times during the school year). A comprehensive range of youth-friendly SRH services, including contraceptive counseling, provision of LARC (implants and IUDs), short-term methods (pills, injectables and emergency contraception), condom promotion, STI services, and referrals to health facilities if needed, will be available to all students through the mobile visits.

Andere namen:
  • Mobile outreach clinics
Experimenteel: CSE + mobile SRH services

The 60 schools in this arm will receive both interventions: they will implement the CSE curriculum (and space spaces) and will also receive MSSL-provided mobile SRH outreach services on the school premises 3 times per school year.

For junior secondary schools in the "CSE only" and "CSE+mobile SRH services" intervention arms, at baseline at the start of the school year, MSSL will train teachers who teach subjects in which CSE topics are included, using a standard teaching training curriculum to help mitigate the risk of variability in the quality of CSE implementation across schools. Teachers will then implement the CSE curriculum in their classes throughout the duration of the study. MSSL will provide yearly refresher teacher training throughout the study. In each school, guidance counselors will be tasked with monitoring implementation of the intervention. MSSL will provide all materials and equipment needed to teach CSE. Each school will create a "safe space" where students can go for menstrual hygiene and care.

Andere namen:
  • CSE
  • Child and Adolescent Health and Life Skills (CAHLS) - name used by the Ministry of Education to refer to the CSE curriculum

For junior secondary schools in the "Mobile SRH services only" and "CSE+mobile SRH services" intervention arms, MSSL will utilize three mobile clinical teams to provide direct, comprehensive SRHR services on-site at schools. Each team will be composed of two service providers trained to provide youth-friendly services, one data imputer, and a transport assistant. The team will visit each school once per quarter (3 times during the school year). A comprehensive range of youth-friendly SRH services, including contraceptive counseling, provision of LARC (implants and IUDs), short-term methods (pills, injectables and emergency contraception), condom promotion, STI services, and referrals to health facilities if needed, will be available to all students through the mobile visits.

Andere namen:
  • Mobile outreach clinics

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Proportion of Adolescent Girls and Young Women (AGYW) Using (or Whose Partner Uses) a Modern Contraceptive Method (mCPR)
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Proportion of female respondents who use, or whose partners use, modern contraceptive methods (female/male sterilization, IUD, implant, injectable, pill, emergency contraception, male/female condom, and modern fertility-awareness-based methods). Aggregated as a proportion at each round; between-arm effect estimated via difference-in-differences.

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Proportion of AGYW Whose Contraceptive Use or Non-Use Is Concordant with Their Fertility Preferences (Preference-Aligned Fertility Management)
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Proportion of female respondents classified as preference-concordant by the Preference-Aligned Fertility Management (PFM) indicator: using contraception and wanting to be, or not using and not wanting to be.

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Proportion of AGYW with Decision-Making Autonomy over Family Planning
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Proportion of female respondents who report being able to make their own decisions regarding the use of family planning, as opposed to needing permission from a parent, partner, healthcare provider, or other household authority figure.

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Proportion of AGYW and Adolescent Boys and Young Men (ABYM) Who Have Dropped Out of School
Tijdsspanne: Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Proportion of the baseline (JSS1-enrolled) cohort of female and male respondents no longer enrolled in / attending school at a given follow-up round. Baseline enrollment is universal by eligibility, so dropout is measured longitudinally across rounds.

Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Unintended Pregnancy Incidence Rate Among AGYW
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Proportion of female respondents who reported a new pregnancy that was unwanted or mistimed since the previous round, based on pregnancy history and retrospective wantedness.

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Proportion of Sexually Active AGYW and ABYM Who Used a Condom at Last Sexual Intercourse
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Among female and male respondents who report having had sex in last 6 months, proportion who report that a condom was used at last intercourse.

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Proportion of AGYW with Unmet Need for Modern Contraception
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Modified unmet-need indicator: Proportion of sexually active non-pregnant female respondents who wish to delay or avoid pregnancy but are not using a modern contraceptive method.

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Proportion of Female Contraceptive Users Who Are Satisfied With Their Method
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Proportion of female contraceptive users who are satisfied with their method

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Incidence of Contraceptive Method Discontinuation Among AGYW
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Among female respondents using a method, proportion who discontinue (stop or have removed) their method between consecutive rounds.

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Marriage/Cohabitation Incidence Rate for AGYW and ABYM
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Proportion of female and male respondents who got married or started cohabiting between two consecutive rounds.

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Mean Score on an Index of SRH Knowledge for AGYW and ABYM
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Mean score on an index of 5 SRH knowledge items among female and male respondents, including potential side effects, infertility, postpartum fertility, and the fertile window.

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Mean Score on the 4-Item Desire to Avoid Pregnancy Scale (DAP-4) for AGYW
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Mean score on the 4-item DAP scale for female respondents. Items include to what extent: 1) becoming pregnant in the next 3 months makes me feel excited, 2) it would be a positive addition to my life to have a baby in the next year, 3) thinking about having a baby within the next year makes me feel stressed out, and 4) if I had a baby in the next year, it would be hard for me to manage raising the child.

Each DAP item has response options that range from 0-4. For negatively worded items, 4 is "strongly agree;" for positively worded items, 4 is "strongly disagree." Sum raw item scores and divide by 14 to obtain an average pregnancy preferences score (final range: 0-4). Higher scores reflect a higher desire to avoid pregnancy. The DAP is intended to be used as a continuous measure.

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Mean Score on the Short 5-item Reproductive Coercion Scale for AGYW
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Proportion of partnered female respondents reporting any of the five reproductive-coercion behaviors on the validated 5-item short-form validated Reproductive Coercion Scale (or the mean item count).

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Mean Score on the Contraceptive Self-Efficacy Among Women in Sub-Saharan Africa (CSESSA) Scale for AGYW
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Mean score on the validated 10-item CSESSA for female respondents. The score is calculated by summing all item values, creating a total score ranging from 0 to 100 across the partner-communication, provider-communication, and choosing/managing-a-method subscales.

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Mean Score on Gender Attitudes and Beliefs for AGYW and ABYM
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Mean score out of 15 items measuring beliefs and attitudes about gender and gender norms, for female and male respondents

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Proportion of AGYW and ABYM Reporting Very Good or Excellent Self-Rated Health
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Proportion of female and male respondents who rated their health as very good or excellent (or mean on the ordinal scale).

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Mean Score on Cantril Life Satisfaction Ladder (Present and Future) for AGYW and ABYM
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Mean score on validated Cantril Self-Anchoring Ladder (present and anticipated 4-year rungs, 0-10), for female and male respondents

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Mean score on PHQ-4 Mental Health Scale (and Proportion Screening Positive for Anxiety or Depression) for AGYW and ABYM
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Mean score on validated 4-item PHQ-4 mental health scale, for female and male respondents (range 0-12). Report the mean total score and the proportion screening positive (subscale total >=3 for anxiety and for depression).Total score is determined by adding together the scores of each of the four items. Scores are rated as normal (0-2), mild (3-5), moderate (6-8), and severe (9-12).

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Mean Score on the Child and Youth Resilience Measure (CYRM-11) for AGYW and ABYM
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Mean score on the validated 11-item CYRM for female and male respondents (simple sum of all 11 items, no reverse-scored items)

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Mean Score on the Global Early Adolescent Study (GEAS) Empowerment Scale for AGYW and ABYM
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Mean score on validated GEAS empowerment scale and 3 subscales (5-item freedom of movement, 7-item voice and 5-item decision-making/behavioral control), for female and male respondents. Mean scores are calculated based on each set of scaled items, ranging from 1 to 4.

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Mean Desired Educational Attainment for AGYW and ABYM
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Mean highest school level that female and male respondents aspire to complete

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Proportion of AGYW and ABYM Who Support the Continuation of Female Genital Cutting
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Proportion of female and male respondents expressing both: 1) support for the continuation of female circumcision, and 2) intention to have a future daughter circumcised (or for boys, desire that their future wife be circumcised).

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Proportion of Partnered AGYW Reporting Intimate Partner Violence in the Past 12 Months
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Among ever-partnered female respondents, proportion reporting any controlling, emotional, physical, sexual, or economic abuse by a current/most-recent partner, using standard DHS/WHO-style items. Reportable overall and by subdomain.

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Proportion of ABYM Able to Challenge Violence
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Proportion of male respondents who have witnessed physical violence by another man who would do something about it

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Andere uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Average Number of Comprehensive Sexuality Education Topics Reported by AGYW and ABYM as Covered in Class
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Average number of CSE topics covered in class during the current school year as reported by female and male respondents

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Proportion of AGYW and ABYM Reporting That Comprehensive Sexuality Education Classes Have Been Useful
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Proportion of female and male respondents who report that CSE classes have been useful or very useful in helping them in their personal life, by trial arm

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Proportion AGYW and ABYM Who Received School-Based Mobile SRH services
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Proportion of female and male respondents who report having attended mobile SRH services at their school or a neighboring school during the current school year

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)
Mean Score on Person-Centered Contraceptive Counseling (PCCC) Scale for AGYW
Tijdsspanne: Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Mean score on validated PCCC scale for female respondents who attended mobile SRH services at their school or a neighboring school during the current school year, based on 4 items

Baseline; Month 6 of intervention; Month 12 of intervention; Month 18 of intervention; Month 24 of intervention; Month 30 of intervention; Month 36 of intervention; Month 42 of intervention; Endline (month 48 of intervention)

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Hannah Olson, PhD, Guttmacher Institute
  • Hoofdonderzoeker: Margaret Giorgio, PhD, Guttmacher Institute
  • Studie directeur: Onikepe Owolabi, PhD, Guttmacher Institute

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

5 oktober 2026

Primaire voltooiing (Geschat)

1 oktober 2029

Studie voltooiing (Geschat)

1 oktober 2029

Studieregistratiedata

Eerst ingediend

30 september 2026

Eerst ingediend dat voldeed aan de QC-criteria

30 september 2026

Eerst geplaatst (Werkelijk)

6 oktober 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

6 oktober 2026

Laatste update ingediend die voldeed aan QC-criteria

30 september 2026

Laatst geverifieerd

1 september 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren